We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Examination of B Cell Responses in Human Blood

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00806845
First Posted: December 11, 2008
Last Update Posted: May 13, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Leipzig
Information provided by (Responsible Party):
Christian Jassoy, Regenerative Medicine Network
December 10, 2008
December 11, 2008
May 13, 2015
July 2008
December 2009   (Final data collection date for primary outcome measure)
Antigen specific B-cell responses [ Time Frame: 18 months ]
Same as current
Complete list of historical versions of study NCT00806845 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Examination of B Cell Responses in Human Blood
Gewinnung Humaner antikörperproduzierender Zellen Aus Dem Blut
The aim of this study is the assessment B-cell immune responses in HIV-infected individuals.
Groups of patients with different immune competencies will be examined. The impact of HIV infection on immune response will be assessed.
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples Without DNA
Description:
peripheral blood
Non-Probability Sample
HIV patients and controls attending specialised clinics, Germany
HIV Infections
Not Provided
  • HIV infected individuals, HIV controllers
    CD4+ T cell count > 350/µl, HIV load < 1000 copies/ml
  • HIV infected individuals, early progressors
    CD4+ T cell count > 350/µl, HIV load > 1000 copies/ml
  • HIV infected individuals, late progressors
    CD4+ T cell count < 200/µl
  • HIV infected individuals, late progressors with therapy
    CD4+ T cell count < 200/µl, under ART
  • Healthy individuals
    Uninfected

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
February 2010
December 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV-infected individuals
  • controls

Exclusion Criteria:

- none

Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00806845
RegMedNet-001
Yes
Not Provided
Not Provided
Christian Jassoy, Regenerative Medicine Network
Regenerative Medicine Network
University of Leipzig
Study Director: Christian Jassoy, MD Universität Leipzig
Regenerative Medicine Network
May 2015